Genomics Services Market Size & Growth Forecast 2027–2036, By Segments (Application, End Use, Service Type), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Genomics Services Market size was worth USD 10.24 Billion in 2026 and is expected to grow at 11.96% CAGR between 2027 and 2036, exceeding USD 31.69 Billion by 2036. The industry revenue for 2027 is calculated at USD 11.3 Billion.
Get more details on this report
Request Free Sample ReportGenomics Services Market Intelligence Snapshot
Regional Market Dynamics
- North America leads through advanced healthcare infrastructure, precision medicine adoption, biotechnology investment, and expanding genomic applications across clinical and research settings.
- Asia Pacific is expanding rapidly as healthcare infrastructure, biotechnology investment, precision medicine adoption, genetic testing awareness, and life sciences research activity increase.
Segment Momentum
- Research applications accounted for 61.06% in 2026, supported by extensive use in genetic studies, biomarker discovery, disease research, and sequencing projects.
- Diagnostics is the fastest-growing application as genomic testing expands across disease detection, precision medicine, and personalized treatment planning in clinical settings.
Market Expansion Drivers
- Technological advancements in high-throughput sequencing accelerating genomics service outsourcing demand
- Increasing use of genomics in personalized medicine enabling precision treatment development
- Rising adoption of clinical-grade genomic diagnostics expanding routine healthcare integration of sequencing services
Leading Market Participants
- Major companies in the genomics services market include Illumina Inc. (United States), Thermo Fisher Scientific Inc. (United States), Agilent Technologies Inc. (United States), BGI Genomics Co., Ltd. (China), QIAGEN N.V. (Germany), Eurofins Scientific SE (Luxembourg), Roche Holding AG (Switzerland), Danaher Corporation (United States), Macrogen Inc. (South Korea), Azenta Life Sciences (United States)
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 10.24 Billion
- 2027 Estimated Market Size: USD 11.3 Billion
- Projected Market Size: USD 31.69 Billion by 2036
- Growth Forecast: 11.96% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Research (Application) | Research Institutes (End Use) | Next Generation Sequencing (Service Type)
- Emerging Opportunity Segment: Diagnostics (Application) | Pharmaceutical and Biotechnological Companies (End Use) | Next Generation Sequencing (Service Type)
Market Growth Drivers and Industry Trends
Technological advancements in high-throughput sequencing accelerating genomics service outsourcing demand
Continuous improvements in high-throughput sequencing technologies are making genomic analysis faster, more scalable, and increasingly cost-efficient, creating favorable conditions that will drive the genomics services market growth. Research institutions, biotechnology companies, and healthcare organizations are outsourcing sequencing activities to specialized service providers equipped with advanced platforms, bioinformatics expertise, and standardized analytical workflows. Outsourcing also enables organizations to expand project capacity, access specialized capabilities without substantial infrastructure investments, and accelerate the delivery of genomic data for research, clinical, and drug discovery applications.
Increasing use of genomics in personalized medicine enabling precision treatment development
The growing emphasis on individualized healthcare is transforming therapeutic development, and the genomics services market is benefiting from the expanding role of genomic insights in precision medicine. Healthcare providers and researchers increasingly rely on genomic profiling to better understand disease mechanisms, identify patient-specific biomarkers, and support targeted treatment selection. Specialized genomics service providers contribute by delivering sequencing, data interpretation, and analytical support that enable more informed clinical research and facilitate the development of therapies tailored to individual genetic characteristics.
Rising adoption of clinical-grade genomic diagnostics expanding routine healthcare integration of sequencing services
The broader incorporation of genomic testing into routine clinical practice will propel the genomics services market growth as healthcare systems integrate sequencing into diagnostic and disease management pathways. Clinical-grade genomic diagnostics require highly accurate sequencing, validated laboratory processes, and comprehensive data interpretation to support reliable medical decision-making across diverse therapeutic areas. This growing integration is increasing demand for specialized service providers capable of delivering regulatory-compliant testing, quality-controlled workflows, and clinically actionable genomic analyses for hospitals, diagnostic laboratories, and healthcare networks.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Technological advancements in high-throughput sequencing accelerating genomics service outsourcing demand | 2.6% | High | North America, Europe, Asia Pacific | High | Near Term |
| Increasing use of genomics in personalized medicine enabling precision treatment development | 2.4% | High | North America, Europe | High | Near Term |
| Rising adoption of clinical-grade genomic diagnostics expanding routine healthcare integration of sequencing services | 2% | High | North America, Asia Pacific | Emerging | Mid Term |
Explore Growth Opportunities
Request Free Sample ReportRegional Demand Dynamics
North America (Largest Region)
The genomics services market was led by North America in 2026, reflecting the region's advanced healthcare and research infrastructure, strong adoption of precision medicine, and extensive use of genomic technologies in clinical and research applications. Growing demand for personalized healthcare is encouraging healthcare providers and research institutions to utilize genomic analysis for disease understanding, diagnosis, treatment selection, and drug development. The region also benefits from substantial investment in biotechnology and medical research, along with increasing awareness of the clinical value of genomic information. Expanding applications in oncology, rare diseases, inherited disorders, and population health are further supporting sustained demand for specialized genomics services.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is projected to register the fastest growth, supported by expanding healthcare infrastructure, rising investment in biotechnology, and increasing adoption of precision medicine. Growing awareness of genetic disorders and the potential of genomic testing is encouraging broader utilization across clinical and research settings. Improvements in healthcare access and the development of advanced diagnostic capabilities are also enabling more institutions to incorporate genomic technologies into disease management. Furthermore, increasing research activity and investment in life sciences are creating a stronger ecosystem for genomic data generation and analysis, positioning the region for rapid expansion in genomics services.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
United States 🇺🇸
Advanced Clinical GenomicsThe U.S. continues to expand genomics services through clinical diagnostics, pharmaceutical research, and precision medicine initiatives. Service providers are investing in scalable sequencing platforms, bioinformatics capabilities, and integrated data analysis to support diverse healthcare applications.
Germany 🇩🇪
Translational Research SupportGermany is strengthening genomics services by connecting academic research with clinical and biopharmaceutical applications. Laboratories are expanding sequencing capacity and advanced analytical services to accelerate translational research and personalized healthcare initiatives.
Japan 🇯🇵
Precision Medicine IntegrationJapan is advancing genomics services to support personalized medicine, rare disease research, and oncology programs. Organizations are improving sequencing quality and clinical data interpretation to enhance the value of genomic insights for healthcare providers.
South Korea 🇰🇷
Biotechnology Collaboration HubSouth Korea is expanding genomics services through collaborations between biotechnology companies, research institutes, and healthcare organizations. Investments are focused on high-throughput sequencing and advanced bioinformatics to strengthen clinical and research capabilities.
France 🇫🇷
Clinical Sequencing ExpansionFrance is increasing the adoption of genomics services across hospital networks and biomedical research programs. Service providers are emphasizing standardized sequencing workflows and secure data management to support precision healthcare and collaborative research.
Italy 🇮🇹
Diagnostic Genomics DevelopmentItaly is strengthening genomics services by expanding access to molecular diagnostics and research-based sequencing solutions. Laboratories are focusing on efficient sample processing and comprehensive genomic analysis to support evolving clinical and academic requirements.
Segment Leadership and Growth Trends
Genomics Services Market Share (%), by Application, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportApplication Segment Analysis: Research (Largest Segment) vs Diagnostics (Fastest-Growing Segment)
The research segment dominated the genomics services market, accounting for the largest share of 61.06% in 2026. Its leading position is driven by extensive utilization of genomics services in genetic research, disease mechanism studies, biomarker discovery, and functional genomics projects conducted by academic and scientific organizations. Continuous expansion of genomics-based research initiatives and increasing demand for high-quality sequencing and analytical services have further strengthened the segment's prominence.
The diagnostics segment is expected to register the fastest growth, supported by the expanding clinical application of genomic testing for disease detection, precision medicine, and personalized treatment planning. Greater integration of genomic information into routine healthcare, coupled with increasing awareness of early diagnosis and advancements in molecular diagnostic technologies, is accelerating demand for specialized genomics services across clinical settings.
End Use Segment Analysis: Research Institutes (Largest Segment) vs Pharmaceutical and Biotechnological Companies (Fastest-Growing Segment)
Research institutes held the largest share in 2026, reflecting their extensive involvement in genomics research, large-scale sequencing projects, and collaborative scientific studies. Strong funding support for life science research, growing emphasis on understanding complex genetic mechanisms, and continuous investment in advanced genomic technologies have enabled research institutes to remain the primary consumers of genomics services across diverse research applications.
The genomics services market is witnessing the fastest growth from pharmaceutical and biotechnological companies as these organizations increasingly integrate genomic insights into drug discovery, biomarker identification, target validation, and precision therapeutics development. Rising investment in personalized medicine and biologics development, together with the growing need for specialized genomic analysis throughout the product development lifecycle, continues to accelerate service adoption within this end-use segment.
Service Type Segment Analysis: Next Generation Sequencing (Largest & Fastest-Growing Segment)
The next generation sequencing segment led the genomics services market and held the largest share in 2026. Its dominance is attributed to its ability to generate comprehensive genomic data with high throughput, making it an essential technology for research, clinical investigations, and precision medicine applications. The technology supports diverse applications including whole genome sequencing, targeted sequencing, transcriptomics, and genetic variant analysis, enabling researchers and healthcare professionals to obtain detailed molecular insights efficiently. Ongoing technological improvements, expanding clinical acceptance, and increasing demand for advanced genomic analysis continue to reinforce next generation sequencing as both the largest and fastest-growing service type segment.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Application | Research, Diagnostics | Research | Diagnostics |
| End Use | Research Institutes, Diagnostic Centers, Pharmaceutical and Biotechnological Companies, Contract Research Organization (CROs), Others | Research Institutes | Pharmaceutical and Biotechnological Companies |
| Service Type | Next Generation Sequencing, Genotyping, Microarray, Sanger Sequencing, Others | Next Generation Sequencing | Next Generation Sequencing |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Competitive Landscape and Market Positioning
Key companies in the genomics services market:
- Illumina, Inc. (United States)
- Thermo Fisher Scientific, Inc. (United States)
- Agilent Technologies, Inc. (United States)
- BGI Genomics Co., Ltd. (China)
- QIAGEN N.V. (Germany)
- Eurofins Scientific SE (Luxembourg)
- Roche Holding AG (Switzerland)
- Danaher Corporation (United States)
- Macrogen, Inc. (South Korea)
- Azenta Life Sciences (United States)
Genomics services market competition is intensifying as providers move from basic sequencing support toward comprehensive analytical capabilities that enable personalized research and healthcare applications. Service providers are strengthening their positions through advanced interpretation platforms, specialized workflows, and the ability to manage increasingly complex genomic datasets. The competitive landscape is also being influenced by demand for faster turnaround, data security, and domain-specific expertise, with organizations that combine laboratory capabilities and computational insights establishing stronger differentiation.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Illumina Inc. (United States) | |||||||
| Thermo Fisher Scientific Inc. (United States) | |||||||
| Agilent Technologies Inc. (United States) | |||||||
| BGI Genomics Co. Ltd. (China) | |||||||
| QIAGEN N.V. (Germany) | |||||||
| Eurofins Scientific SE (Luxembourg) | |||||||
| Roche Holding AG (Switzerland) | |||||||
| Danaher Corporation (United States) | |||||||
| Macrogen Inc. (South Korea) | |||||||
| Azenta Life Sciences (United States) |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Daisy Genomics | Dec-25 | Daisy Genomics secured USD 25 million in funding to advance its precision medicine sequencing platform, expanding its operational capabilities and commercial presence within the genomics sector. |
| Galatea Bio | Mar-25 | Galatea Bio raised USD 25 million in capital financing to accelerate global genomic research and expand its precision medicine capabilities within the market. |
| IQVIA | Dec-24 | IQVIA entered into a strategic partnership with NVIDIA to integrate artificial intelligence into life sciences, focusing on accelerating drug discovery and strengthening data analysis for genomics services. |
| Eurofins | Aug-24 | Eurofins finalized the acquisition of UK-based DNA and forensic testing company Orchid Cellmark, broadening its technical expertise and expanding its market position in advanced genetic analysis. |
| Danaher | Jan-24 | Danaher collaborated with the Innovative Genomics Institute to launch the Danaher-IGI Beacon for CRISPR Cures, aiming to fast-track gene-editing therapies for rare diseases and expand its market footprint. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Genomics Services Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Sample Type | Blood, Tissue, Saliva & Buccal Samples, Urine, Other Biological Samples |
| Service Delivery Model | Centralized Laboratory Services, On-site Laboratory Services, Hybrid Services |
| Contract Model | Project-Based Contracts, Recurring Service Contracts, Long-Term Strategic Contracts |
Genomics Services Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Genomics Outsourcing Decision Framework |
|
| Service Provider Partnership Models |
|
| Genomic Data Commercialization Opportunities |
|
Need a different cut of the data?
Request Custom ResearchHow large is the genomics services market?
What is the anticipated CAGR of the genomics services industry?
How is high-throughput sequencing influencing outsourcing strategies in the genomics services market?
Why is personalized medicine increasing demand for genomics service providers?
Why does the research segment dominate the genomics services market?
How are diagnostics applications accelerating genomics services growth?
Why does North America lead the genomics services market?
What is driving rapid genomics services growth in Asia Pacific?
Who holds a significant market share in the genomics services landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization